Anticancer therapeutic potential of phosphorylated galactosylated chitosan against N-nitrosodiethyl amine-induced hepatocarcinogenesis
Authors:
- 12 August 2022
- journal article
- research article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 728, 109375
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Role of Nitrative and Oxidative DNA Damage in Inflammation-Related CarcinogenesisJournal of Biomedicine and Biotechnology, 2012
- Nanocarriers for Cytoplasmic Delivery: Cellular Uptake and Intracellular Fate of Chitosan and Hyaluronic Acid‐Coated Chitosan Nanoparticles in a Phagocytic Cell ModelMacromolecular Bioscience, 2011
- Chitosan-based macrophage-mediated drug targeting for the treatment of experimental visceral leishmaniasisJournal of Microencapsulation, 2011
- Hepatitis B and C Viruses and Hepatocellular CarcinomaViruses, 2010
- Preparation of nano‐chitosan Schiff‐base copper complexes and their anticancer activityPolymers for Advanced Technologies, 2008
- Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein−Ligand ComplexesJournal of Medicinal Chemistry, 2006
- Chemical modification of chitosan by phosphorylation: an XPS, FT-IR and SEM studyJournal of Biomaterials Science, Polymer Edition, 2005
- Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database ScreeningJournal of Medicinal Chemistry, 2004
- Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liverBiochimica et Biophysica Acta (BBA) - General Subjects, 1979
- Glutathione peroxidase activity in selenium-deficient rat liverBiochemical and Biophysical Research Communications, 1976